Aliskiren and Valsartan reduce myocardial AT1 receptor expression and limit myocardial infarct size in diabetic mice (Q47350464)

14 January 2018

title

Aliskiren and Valsartan reduce myocardial AT1 receptor expression and limit myocardial infarct size in diabetic mice (English)

1 reference

14 January 2018

author name string

Yumei Ye

1

1 reference

14 January 2018

Jinqiao Qian

2

1 reference

14 January 2018

Alexander C Castillo

3

1 reference

14 January 2018

Jose Regino Perez-Polo

4

1 reference

14 January 2018

Yochai Birnbaum

5

1 reference

14 January 2018

publication date

1 December 2011

1 reference

14 January 2018

Cardiovascular Drugs and Therapy

published in

1 reference

14 January 2018

volume

25

1 reference

14 January 2018

issue

6

1 reference

14 January 2018

page(s)

505-515

1 reference

14 January 2018

Comparative effects of aspirin with ACE inhibitor or angiotensin receptor blocker on myocardial infarction and vascular function

cites work

1 reference

https://api.crossref.org/works/10.1007%2FS10557-011-6339-Z

Angiotensin II receptor antagonist EXP 3174 reduces infarct size comparable with enalaprilat and augments preconditioning in the pig heart

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10557-011-6339-Z

Differential effects of long-term renin-angiotensin system blockade on limitation of infarct size in cholesterol-fed rabbits

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10557-011-6339-Z

Effects of captopril and losartan on myocardial ischemia-reperfusion induced arrhythmias and necrosis in rats

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10557-011-6339-Z

Quinaprilat reduces myocardial infarct size involving nitric oxide production and mitochondrial KATP channel in rabbits

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10557-011-6339-Z

Effects of ACE inhibition on myocardial apoptosis in an ischemia-reperfusion rat heart model

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10557-011-6339-Z

High tissue affinity angiotensin-converting enzyme inhibitors improve endothelial function and reduce infarct size

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10557-011-6339-Z

Cellular mechanisms of cardioprotection afforded by inhibitors of angiotensin converting enzyme in ischemic hearts: role of bradykinin and nitric oxide

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10557-011-6339-Z

The role of bradykinin and nitric oxide in the cardioprotective action of ACE inhibitors.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10557-011-6339-Z

Reduction of myocardial infarct size by ramiprilat is independent of angiotensin II synthesis inhibition

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10557-011-6339-Z

Enhanced reduction of myocardial infarct size by combined ACE inhibition and AT(1)-receptor antagonism

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10557-011-6339-Z

Infarct size reduction by AT1-receptor blockade through a signal cascade of AT2-receptor activation, bradykinin and prostaglandins in pigs

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10557-011-6339-Z

Additive effect of TAK-491, a new angiotensin receptor blocker, and pioglitazone, in reducing myocardial infarct size

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10557-011-6339-Z

Cardioprotective effects of angiotensin II type 1 receptor blockade with candesartan after reperfused myocardial infarction: role of angiotensin II type 2 receptor.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10557-011-6339-Z

AT2 receptor and apoptosis during AT1 receptor blockade in reperfused myocardial infarction in the rat.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10557-011-6339-Z

AT1 receptor blockade in experimental myocardial ischemia/reperfusion

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10557-011-6339-Z

Upregulation of Angiotensin II Type 2 Receptor and Limitation of Myocardial Stunning by Angiotensin II Type 1 Receptor Blockers during Reperfused Myocardial Infarction in the Rat

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10557-011-6339-Z

Aliskiren: a review of its use as monotherapy and as combination therapy in the management of hypertension

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10557-011-6339-Z

Direct renin inhibition: clinical pharmacology

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10557-011-6339-Z

Translating novel strategies for cardioprotection: the Hatter Workshop Recommendations

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10557-011-6339-Z

Angiotensin II type 1 receptor-mediated upregulation of calcineurin activity underlies impairment of cardioprotective signaling in diabetic hearts

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10557-011-6339-Z

Myocardial infarction in diabetic vs non-diabetic subjects. Survival and infarct size following therapy with sulfonylureas (glibenclamide)

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10557-011-6339-Z

Preconditioning the diabetic heart: the importance of Akt phosphorylation

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10557-011-6339-Z

Cardioprotection with postconditioning: loss of efficacy in murine models of type-2 and type-1 diabetes

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10557-011-6339-Z

Diabetes mellitus abrogates erythropoietin-induced cardioprotection against ischemic-reperfusion injury by alteration of the RISK/GSK-3β signaling.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10557-011-6339-Z

AKT signalling in the failing heart

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10557-011-6339-Z

Acute activation and phosphorylation of endothelial nitric oxide synthase by HMG-CoA reductase inhibitors

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10557-011-6339-Z

Sirt1 regulates aging and resistance to oxidative stress in the heart

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10557-011-6339-Z

Resveratrol improves health and survival of mice on a high-calorie diet

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10557-011-6339-Z

Mammalian sirtuins: biological insights and disease relevance

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10557-011-6339-Z

The myocardial infarct size-limiting effect of sitagliptin is PKA-dependent, whereas the protective effect of pioglitazone is partially dependent on PKA.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10557-011-6339-Z

Renin inhibition and atherosclerosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10557-011-6339-Z

Beneficial cardiac effects of the renin inhibitor aliskiren in spontaneously hypertensive rats

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10557-011-6339-Z

Renin-angiotensin system revisited

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10557-011-6339-Z

Valsartan-induced cardioprotection involves angiotensin II type 2 receptor upregulation in dog and rat models of in vivo reperfused myocardial infarction

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10557-011-6339-Z

AT1 receptor blockade limits myocardial injury and upregulates AT2 receptors during reperfused myocardial infarction

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10557-011-6339-Z

Improved balance between TIMP-3 and MMP-9 after regional myocardial ischemia-reperfusion during AT1 receptor blockade

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10557-011-6339-Z

Valsartan preconditioning protects against myocardial ischemia-reperfusion injury through TLR4/NF-kappaB signaling pathway

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10557-011-6339-Z

Handle region peptide counteracts the beneficial effects of the Renin inhibitor aliskiren in spontaneously hypertensive rats.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10557-011-6339-Z

Direct renin inhibition improves systemic insulin resistance and skeletal muscle glucose transport in a transgenic rodent model of tissue renin overexpression.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10557-011-6339-Z

Survival kinases in ischemic preconditioning and postconditioning.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10557-011-6339-Z

Valsartan regulates the interaction of angiotensin II type 1 receptor and endothelial nitric oxide synthase via Src/PI3K/Akt signalling

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10557-011-6339-Z

Role of angiotensin II and oxidative stress in vascular insulin resistance linked to hypertension.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10557-011-6339-Z

N-acetylcysteine abolishes the protective effect of losartan against left ventricular remodeling in cardiomyopathy hamster.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10557-011-6339-Z

Renin inhibition attenuates insulin resistance, oxidative stress, and pancreatic remodeling in the transgenic Ren2 rat.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10557-011-6339-Z

Renin inhibitor aliskiren improves impaired nitric oxide bioavailability and protects against atherosclerotic changes

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10557-011-6339-Z

Renin inhibition improves cardiac function and remodeling after myocardial infarction independent of blood pressure

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10557-011-6339-Z

Ischemic postconditioning in pigs: no causal role for RISK activation.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10557-011-6339-Z

The nitric oxide hypothesis of late preconditioning

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10557-011-6339-Z

The role of eNOS, iNOS, and NF-kappaB in upregulation and activation of cyclooxygenase-2 and infarct size reduction by atorvastatin

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10557-011-6339-Z

Angiotensin II type 1 receptor blocker preserves tolerance to ischemia-reperfusion injury in Dahl salt-sensitive rat heart

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10557-011-6339-Z

Attenuation of angiotensin II signaling recouples eNOS and inhibits nonendothelial NOX activity in diabetic mice

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10557-011-6339-Z

SIRT1, a longevity gene, downregulates angiotensin II type 1 receptor expression in vascular smooth muscle cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10557-011-6339-Z

Protective role of SIRT1 in diabetic vascular dysfunction

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10557-011-6339-Z

Resveratrol pretreatment protects rat brain from cerebral ischemic damage via a sirtuin 1-uncoupling protein 2 pathway

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10557-011-6339-Z

Icariin protects against brain injury by enhancing SIRT1-dependent PGC-1alpha expression in experimental stroke

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10557-011-6339-Z

Silent information regulator 1 protects the heart from ischemia/reperfusion

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10557-011-6339-Z

The deacetylase SIRT1 promotes membrane localization and activation of Akt and PDK1 during tumorigenesis and cardiac hypertrophy

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10557-011-6339-Z

SIRT1 controls the transcription of the peroxisome proliferator-activated receptor-gamma Co-activator-1alpha (PGC-1alpha) gene in skeletal muscle through the PGC-1alpha autoregulatory loop and interaction with MyoD.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10557-011-6339-Z

Intra-coronary administration of cyclosporine limits infarct size, attenuates remodeling and preserves left ventricular function in porcine acute anterior infarction

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10557-011-6339-Z

Cyclosporine A at reperfusion reduces infarct size in pigs

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10557-011-6339-Z

Transient upregulation of PGC-1alpha diminishes cardiac ischemia tolerance via upregulation of ANT1.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10557-011-6339-Z

PGC-1alpha over-expression promotes recovery from mitochondrial dysfunction and cell injury

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10557-011-6339-Z

10.1007/S10557-011-6339-Z

21 January 2018

Identifiers

DOI

1 reference

14 January 2018

release_jxqdpqcbejbtfj5edj5gu3lc74

Fatcat ID

1 reference

Fatcat

https://api.fatcat.wiki/v0/release/jxqdpqcbejbtfj5edj5gu3lc74

mapped directly with Wikidata item

24 November 2022

based on heuristic

PubMed ID

21987107

1 reference

14 January 2018